Richa Rathore

622 total citations
21 papers, 417 citations indexed

About

Richa Rathore is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Richa Rathore has authored 21 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Richa Rathore's work include Sarcoma Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Richa Rathore is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Richa Rathore collaborates with scholars based in United States, Canada and United Kingdom. Richa Rathore's co-authors include Brian A. Van Tine, Bethany C. Prudner, Angela C. Hirbe, Charles R. Schutt, Anthony M. Robinson, Tyler Ball, Thomas J. Meade, Luke Vistain, William G. Hawkins and Adam T. Preslar and has published in prestigious journals such as Journal of Clinical Oncology, Chemical Communications and Clinical Cancer Research.

In The Last Decade

Richa Rathore

21 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richa Rathore United States 11 191 130 127 117 49 21 417
Elizabeth Stewart United States 13 207 1.1× 76 0.6× 115 0.9× 138 1.2× 57 1.2× 21 416
Jordan F. Hastings Australia 8 256 1.3× 106 0.8× 49 0.4× 127 1.1× 25 0.5× 13 455
Victoria Harding United Kingdom 12 335 1.8× 284 2.2× 62 0.5× 110 0.9× 27 0.6× 16 509
Daiki Taniyama Japan 14 277 1.5× 123 0.9× 108 0.9× 267 2.3× 15 0.3× 46 527
Luuk J. Schipper Netherlands 7 74 0.4× 165 1.3× 82 0.6× 224 1.9× 34 0.7× 13 372
Hao Mo China 13 226 1.2× 85 0.7× 86 0.7× 135 1.2× 24 0.5× 32 436
Qiuhui Li China 11 221 1.2× 113 0.9× 167 1.3× 229 2.0× 18 0.4× 26 508
Marie Morfouace France 10 281 1.5× 162 1.2× 65 0.5× 91 0.8× 49 1.0× 25 503
Gonzalo Lopez United States 15 505 2.6× 201 1.5× 174 1.4× 160 1.4× 58 1.2× 21 721
Jamie Sheren United States 8 313 1.6× 143 1.1× 282 2.2× 164 1.4× 49 1.0× 9 599

Countries citing papers authored by Richa Rathore

Since Specialization
Citations

This map shows the geographic impact of Richa Rathore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richa Rathore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richa Rathore more than expected).

Fields of papers citing papers by Richa Rathore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richa Rathore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richa Rathore. The network helps show where Richa Rathore may publish in the future.

Co-authorship network of co-authors of Richa Rathore

This figure shows the co-authorship network connecting the top 25 collaborators of Richa Rathore. A scholar is included among the top collaborators of Richa Rathore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richa Rathore. Richa Rathore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oyama, Toshinao, Richa Rathore, Katharine E. Caldwell, et al.. (2025). PHGDH inhibition and FOXO3 modulation drives PUMA-dependent apoptosis in osteosarcoma. Cell Death and Disease. 16(1). 89–89. 2 indexed citations
2.
Bowles, Tawnya L., Elliot A. Asare, Kenneth F. Grossmann, et al.. (2023). Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma. Melanoma Research. 33(3). 184–191. 8 indexed citations
3.
Salawu, Abdulazeez, Elizabeth G. Demicco, Peter Chung, et al.. (2023). Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS).. Journal of Clinical Oncology. 41(16_suppl). 11509–11509. 4 indexed citations
4.
Prudner, Bethany C., Richa Rathore, Katharine E. Caldwell, et al.. (2022). Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102. Clinical Cancer Research. 28(16). 3573–3589. 19 indexed citations
5.
Akaike, Tomoko, Daniel S. Hippe, Kristina Lachance, et al.. (2022). The relationship between circulating tumor DNA with Merkel cell carcinoma tumor burden and detection of recurrence.. Journal of Clinical Oncology. 40(16_suppl). 9566–9566. 7 indexed citations
6.
Onyshchenko, Mykola, et al.. (2022). Clinical utility of circulating tumor DNA in patients with head and neck cancers.. Journal of Clinical Oncology. 40(16_suppl). e18003–e18003. 1 indexed citations
7.
Rathore, Richa, Katharine E. Caldwell, Charles R. Schutt, et al.. (2021). Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma. Cell Reports. 34(4). 108678–108678. 38 indexed citations
8.
Rathore, Richa & Brian A. Van Tine. (2021). Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies. Journal of Clinical Medicine. 10(6). 1182–1182. 87 indexed citations
9.
Tine, Brian A. Van, Angela C. Hirbe, Peter Oppelt, et al.. (2021). Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma. Clinical Cancer Research. 27(14). 3854–3860. 16 indexed citations
10.
Rathore, Richa, et al.. (2020). Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming. Cell Death and Disease. 11(8). 662–662. 15 indexed citations
11.
Rathore, Richa, Charles R. Schutt, & Brian A. Van Tine. (2020). PHGDH as a mechanism for resistance in metabolically-driven cancers. Cancer Drug Resistance. 3. 762–774. 33 indexed citations
12.
Prudner, Bethany C., Richa Rathore, Anthony M. Robinson, et al.. (2019). Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors. Clinical Cancer Research. 25(16). 5122–5134. 52 indexed citations
13.
Robinson, Anthony M., Richa Rathore, Douglas R. Adkins, et al.. (2019). Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma. Cell Death and Disease. 10(11). 867–867. 35 indexed citations
14.
Prudner, Bethany C., Tyler Ball, Richa Rathore, & Angela C. Hirbe. (2019). Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives. Neuro-Oncology Advances. 2(Supplement_1). i40–i49. 41 indexed citations
15.
Sharma, Rajeev, et al.. (2018). A prospective study of risk factors of mortality in neonatal sepsis patients. International journal of applied research. 3(1). 72–74. 3 indexed citations
16.
Vistain, Luke, Matthew W. Rotz, Richa Rathore, Adam T. Preslar, & Thomas J. Meade. (2015). Targeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imaging. Chemical Communications. 52(1). 160–163. 24 indexed citations
17.
Vistain, Luke, et al.. (2015). Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a CoIII‐Ebox Conjugate. ChemBioChem. 16(14). 2065–2072. 17 indexed citations
18.
Rathore, Richa, R. A. Coward, & Alexander Woywodt. (2012). What's in a name? Bence Jones protein. Clinical Kidney Journal. 5(5). 478–483. 7 indexed citations
19.
Rathore, Richa, et al.. (2011). Sepsis and a painful shoulder in a haemodialysis patient. Clinical Kidney Journal. 4(6). 439–442. 1 indexed citations
20.
Rathore, Richa, et al.. (2011). FUNCTIONAL OUTCOMES FOLLOWING SURGERY FOR BONE SARCOMAS. 6–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Stewart Breakdown of academic impact, for papers by Jordan F. Hastings Breakdown of academic impact, for papers by Victoria Harding Breakdown of academic impact, for papers by Daiki Taniyama Breakdown of academic impact, for papers by Luuk J. Schipper Breakdown of academic impact, for papers by Hao Mo Breakdown of academic impact, for papers by Qiuhui Li Breakdown of academic impact, for papers by Marie Morfouace Breakdown of academic impact, for papers by Gonzalo Lopez Breakdown of academic impact, for papers by Jamie Sheren
Rankless by CCL
2026